A tennis participant has been suspended after testing constructive for a banned substance.

Romeo Arcuschin, 18, has been suspended by the Worldwide Tennis Integrity Company (Picture: Getty)
A teenage tennis participant has been suspended by the Worldwide Tennis Integrity Company (ITIA) after failing a medication take a look at final 12 months. Romeo Arcuschin, 18, from Argentina, reached a career-high rating of 1802 in the direction of the top of 2025. Again in December, he supplied a pattern for testing whereas taking part in at an ITF World Tennis Tour occasion in Peru.
Subsequent evaluation discovered that his pattern contained a metabolite of stanozolol, a banned artificial anabolic-androgenic steroid. A second ‘B’ pattern was analysed in February and confirmed the preliminary findings from the ‘A’ pattern. Due to this, Arcuschin has been hit with a provisional suspension, banning him from all professionally sanctioned occasions till additional discover.
In a press release on Tuesday, the ITIA mentioned: “The ITIA despatched the participant a pre-charge discover of an Anti-Doping Rule Violation on 16 February 2026 below Article 2.1 of the TADP (presence of a Prohibited Substance in a Participant’s Pattern) and/or Article 2.2 (Use of a Prohibited Substance with no legitimate Therapeutic Use Exemption (TUE)).
“Arcuschin, who reached a career-high world singles rating of 1802 in November 2025, supplied an in-competition pattern whereas competing in an ITF World Tennis Tour M15 occasion in Lima, Peru, on 15 December 2025.
“The pattern was cut up into A and B samples and the following evaluation discovered that the A pattern contained a metabolite of stanozolol.
“The substance is prohibited below the TADP within the class of Anabolic Brokers (Part S1.1) of the 2025 Prohibited Checklist. The B pattern was analysed on 23 February 2026 and confirmed the findings of the A pattern.
“As stanozolol is a non-specified substance, a compulsory provisional suspension is required. In Arcuschin’s case this has been in impact from 16 February 2026.

















Leave a Reply